Urgent

Congenital hypothyroidism

Screen-positive, start early · Paediatric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Congenital hypothyroidism is the commonest preventable cause of neurodevelopmental impairment, usually detected by newborn bloodspot screening before symptoms appear. Early thyroxine replacement — ideally within the first 1-2 weeks of life — is essential to protect the developing brain.

Red flags

  • Markedly elevated screening TSH with very low free T4
  • Delay beyond 2 weeks of age in starting treatment
  • Features of severe hypothyroidism (prolonged jaundice, poor feeding, constipation, hypotonia, large fontanelle, goitre)
  • Suspected central hypothyroidism with other pituitary hormone deficiency
  • Non-adherence/absorption failure on follow-up

Assessment

Differential diagnosis

  • Primary CH (thyroid dysgenesis or dyshormonogenesis)
  • Central/secondary (hypothalamic-pituitary) hypothyroidism
  • Transient hypothyroidism (iodine exposure, maternal antithyroid drugs, maternal TSH-receptor-blocking antibodies)
  • Preterm/sick euthyroid changes
  • Prematurity-related transient hypothyroxinaemia

Investigations

  • Newborn bloodspot screening TSH (primary screen) — act urgently on positives
  • Confirmatory venous free T4 and TSH
  • Thyroid ultrasound and/or radionuclide (Tc/iodine) scan to define aetiology (do not delay treatment for it)
  • Maternal thyroid history and TSH-receptor antibody status if relevant
  • Thyroglobulin and urinary iodine in selected cases
  • Knee X-ray for distal femoral epiphysis (marker of intrauterine hypothyroidism) if indicated

Management

  • Treat a screen-positive/confirmed case as urgent — the priority is prompt thyroxine, not complete work-up
  • Take confirmatory venous free T4 and TSH, then start treatment without waiting if screening strongly positive
  • Start levothyroxine at 10-15 microgram/kg once daily, crushed in a little water/milk, by mouth
  • Use the higher end of the range for severe cases (very high TSH, very low T4)
  • Recheck free T4 and TSH within 1-2 weeks of starting and after dose changes
  • Titrate to normalise free T4 quickly and keep TSH in the target range
  • Arrange aetiological imaging (ultrasound/scan) but never delay treatment for it
  • Avoid giving thyroxine with soya, iron or calcium feeds/preparations that impair absorption
  • Counsel parents on adherence, administration technique and the importance of early treatment
  • Arrange paediatric endocrinology follow-up with regular biochemical monitoring and developmental surveillance

Drugs & doses

Levothyroxine 10-15 microgram/kg PO once daily (higher end for severe CH), titrated to free T4/TSH
Administer dissolved in a small volume of water or breast milk; avoid co-administration with soya/iron/calcium
Adjust dose by weight gain and serial thyroid function tests

Disposition

Urgent paediatric endocrinology referral and early treatment; regular biochemical and developmental monitoring through childhood. Re-evaluation of the diagnosis around age 3 if aetiology uncertain.

Complications & pitfalls

  • Irreversible intellectual disability if treatment delayed
  • Growth impairment
  • Overtreatment causing craniosynostosis/temperament effects
  • Undertreatment with persistent developmental risk
  • Missed associated pituitary deficiencies in central CH

Exam pearls

  • Screening detects it before clinical signs — act on positives within days, not weeks
  • Outcome is excellent with timely, adequate replacement; delay is the enemy
  • The TSH-based newborn screen can miss central hypothyroidism — stay alert to clinical signs
  • Soya, iron and calcium reduce levothyroxine absorption — separate their timing

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.